Strongyloidiasis: an emerging infectious disease that simulates allergic diseases.
Allergy Unit, Hospital General Universitario, Valencia, Spain. ddelasma@yahoo.es
M D
MD
de las Marinas
A
A
Martorell
R
R
Felix
J C
JC
Cerdá
A
A
García
D
D
Navalpotro
D000328:Adult; D000818:Animals; D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000009:adverse effects; D021821:Communicable Diseases, Emerging / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D003371:Cough / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D003937:Diagnosis, Differential; D004781:Environmental Exposure / Q000009:adverse effects; D005243:Feces / Q000469:parasitology; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D007073:Immunoglobulin E / Q000097:blood; D007559:Ivermectin / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D013321:Strongyloides / Q000302:isolation & purification* / Q000502:physiology; D013322:Strongyloidiasis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D017211:Treatment Failure; D053833:Wetlands
D018926:Anti-Allergic Agents; D007073:Immunoglobulin E; D007559:Ivermectin